FYARRO
Live / Registered — Registered (as of 09 Aug 2022)
What this means for you
Registered since 09 Aug 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88984193
- Registration number
- 6815686
- Mark type
- Stylized text
- Filed
- 30 Aug 2019
- Published for opposition
- 28 Jul 2020
- Registered
- 09 Aug 2022
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in oncology; pharmaceutical preparations for the treatment of physiological diseases
Owner
- AADi Bioscience, Inc., Morristown, NJ, US
- AADi Bioscience, Inc., Pacific Palisades, CA, US
- AADi Bioscience, Inc., Pacific Palisades, CA, US
Prosecution history
- 24 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 24 Oct 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 24 Oct 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 09 Aug 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 09 Aug 2022 — REGISTERED-PRINCIPAL REGISTER
- 06 Jul 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Jul 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Jun 2022 — ASSIGNED TO EXAMINER
- 06 May 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Mar 2022 — USE AMENDMENT FILED
- 06 May 2022 — DIVISIONAL PROCESSING COMPLETE
- 21 Mar 2022 — DIVISIONAL REQUEST RECEIVED
- 11 Apr 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED